Navigation Links
FDA Approval for Lung Cancer Treatment -Avastin Along with Chemotherapy

The FDA has approved the drug bevacizumab (Avastin) for first time treatment of advanced lung cancer in conjunction with chemotherapy. // This comes after a large randomised study on lung cancer patients led by Dr.Alan Sandler, lung cancer specialist and director of Thoracic Oncology at Vanderbilt-Ingram Cancer Center.

Nearly 900 patients with non-small cell lung cancer (NSCLC) were tested during the trial. None of them had received any previous chemotherapy. Half were given Avastin along with standard chemotherapy drugs while the others were given chemotherapy alone. The study revealed that patients on Avastin survived an average of two months longer than the usual one year survival rate.

Though this does not sound wonderful, it is important to bear in mind that the results were based on average reactions. In some people the survival was even longer, while in others the tumours shrunk and disappeared. However there was no response in some patients.

Bevacizumab is a targeted drug, which means that it does not attack non-cancerous cells. It acts by stopping development of new blood vessels, which supply the tumours. The side effects are generally mild. However a unique and serious one is bleeding from the primary tumour, since the drug acts on the blood vessels; this has to be addressed.

Dr. Sandler is hopeful that the drug will prove path breaking and lead to better survival rates and also to more patients being cured if the disease is caught early. As NSCLC is the most common form of lung cancer in the US, this is encouraging news indeed.
SRM
'"/>




Page: 1

Related medicine news :

1. Approval for DNA test to detect cystic fibrosis
2. Vaccine For Cervical Cancer Awaits Approval
3. WHO Gives Its Approval For Bird Flu Test Kit
4. FDA Gives Its Approval For Inhaler
5. RotaTeq Gets US Approval
6. Better Communication With FDA Could Speed Up Approval Of New Drugs
7. Nerve Stimulator for Depression Though Not Effective Was Given Approval
8. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
9. Global Education Net Pvt Medical College Gets MCI Approval
10. Approval of Drugs for the Treatment of Late-Stage Cancer
11. Lupin Gets USFDA Approval For Quinapril Tablets

Post Your Comments:
(Date:11/26/2009)...is & Ennis, P.A. is offering free nationwide c...min birth control pills who have suffered a Deep V...Heart Attack or other related cardiac issues or ha...ree at 1-800-856-6405 or go to the firm’s we... online case evaluation form. , ...
(Date:11/25/2009)...wire/-SentinelleMedicalInc.,aleadingmanufacturerof...chesasuiteofnewleadingedgeclinicalapplicationsonit...,sRadiologicalSocietyofNorthAmerica(RSNA)annualmee...heapplicationsleveragetheuniquehighqualityimagesge...supportmultipleimagingmodalitiesformulti-parametri...
(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...
(Date:11/25/2009)...s too short to draw definite conclusions, experts ...News) -- In diabetic patients with blocked coronar...utcomes at one year whether patients undergo bypas...searchers report. , Bypass surgery has been the...onary artery disease. However, less invasive appro...
(Date:11/25/2009)...es few signs of trouble with the H1N1 vaccine, ,... The ongoing H1N1 swine flu pandemic may be drivin...nger patients, a U.S. health official said Wednesd...umococcal infections around the country," Dr. Anne...unization and Respiratory Diseases at the U.S. Cen...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...ion, Training and Resources, WASHINGTON, Dec. 6 ...unced it will provide nearly $4.7 million,for "car...prove health care,education and provide needed tra...mily members,and other caregivers who sacrifice to...
...hua-PRNewswire-FirstCall/ -- China Shenghuo,Pharma...mpany") (Amex:,KUN), which is engaged in the resea...armaceutical, nutritional supplement and cosmetic ...s,12Ways(R) Chinese Herbal Cosmetics on China Cent...
...y might prevent cardiac arrest , , THURSDA...,re moving closer to using transplanted cells to p...n cardiac arrest. , Working with mice, scientists...-author Dr. Michael Kotlikoff, a professor in the ...
... First Half of 2008 -, SAN DIEGO and INDIANAPOLIS...MLN ) and Eli Lilly and Company (NYSE: LLY ),toda...monotherapy, or,stand-alone, BYETTA (exenatide) in...wed significant reductions in A1C (a,measure of av...
...oducts to Reach Sales of $1 Billion or More in ...ipeline Offers Promising Outlook; 6 Launches Expec... - R&D Investment and Productivity Gains plus Aggr...t Outcomes,- Lilly Reconfirms 2007 Sales and Earni...
...y, the nation,s leading,oncology services company,...xecutive vice president and chief operating office... 2008., "Glen,s Fortune 500 operating experience,...nt of US Oncology.,"His proven success in working ...
Other Medicine News:Health News:VA Announces $4.7 Million to Help Caregivers 2Health News:VA Announces $4.7 Million to Help Caregivers 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008 3Health News:Cell Transplants Hold Promise for Heart Attack Survivors 2Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 2Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 3Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 4Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 5Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 6Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 2Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 3Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 4Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 5Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 6Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 7Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 8Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 9Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 10Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 11Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 12Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 13Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 14Health News:US Oncology Appoints Glen Laschober EVP & Chief Operating Officer 2
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...-CempraPharmaceuticalsInc.todayannouncedthatPrabha...illpresentatthePiperJaffray21stAnnualHealthCareCon...laceHotelinNewYorkCity.Dr.Fernandeswillprovideanov...ogramsforthetreatmentofdrug-resistantpathogensincl..., Foundedin2006,CempraPharmaceuticalsisaprivately-...
(Date:11/25/2009)...Newswire-FirstCall/--HeartWareInternational,Inc.(N...oflessinvasive,miniaturizedcirculatorysupporttechn...ailure,todayannouncedthatitisscheduledtomakeaninve...areConferenceat8:00amESTonWednesday,December2,2009...ecember1-2. ,, AlivewebcastoftheCompany,spresen...
Breaking Medicine Technology:Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 1Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 2Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 3New Technique Offers Hope for Kids With Immune Deficiency 55986 1New Technique Offers Hope for Kids With Immune Deficiency 55986 2PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 1PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 2
...t Lymphoma Meeting in Lugano, Switzerland, SOUTH ...d an abstract providing preliminary results of a P...788 (fostamatinib disodium), in,patients with rela...(NHL).,The abstract reports favorable responses fo...ma/chronic lymphocytic leukemia (SLL/CLL) or from ...
...f., June 2 Rigel,Pharmaceuticals, Inc. (Nasdaq: ...nce call with simultaneous webcast to discuss the ...of R788, a novel, oral Syk kinase,inhibitor, in pa...day, June,3, 2008 at 8:00 a.m. EDT. Participating ...e principal investigator on the study, Jonathan Fr...
Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: